Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells

Biological Chemistry

Volumn 389, Issue 6, 2008, Pages 757-764

  Henkhaus, Rebecca S ^a   Gerner, Eugene W ^a   Ignatenko, Natalia A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cell migration; Colon cancer; K Ras oncogene; Kallikrein 6; Matrigel invasion

Indexed keywords

KALLIKREIN 6; LAMININ; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; SMALL INTERFERING RNA;

CANCER CELL; CELL INVASION; CELL MIGRATION; CELL SECRETION; CELL STRAIN CACO 2; COLON CARCINOMA; CONFERENCE PAPER; MEDIATOR; MUTATION; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; COLONIC NEOPLASMS; DRUG COMBINATIONS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOGLOBULIN G; INTRACELLULAR SPACE; KALLIKREINS; LAMININ; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 47549105735     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.087     Document Type: Conference Paper

References (32)

1. Adari, H., Lowy, D.R., Willumsen, B.M., Der, C.J., and McCormick, F. (1988). Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240, 518-521.
2. Albini, A., Benelli, R., Noonan, D.M., and Brigati, C. (2004). The 'chemoinvasion assay': a tool to study tumor and endothelial cell invasion of basement membranes. Int. J. Dev. Biol. 48, 563-571.
3. Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
4. Blaber, S.I., Scarisbrick, I.A., Bernett, M.J., Dhanarajan, P., Seavy, M.A., Jin, Y., Schwartz, M.A., Rodriguez, M., et al. (2002). Enzymatic properties of rat myelencephalon-specific protease. Biochemistry 41, 1165-1173.
5. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
6. Bos, J.L. (1989). Ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
7. Caron, R.W., Yacoub, A., Li, M., Zhu, X., Mitchell, C., Hong, Y., Hawkins, W., Sasazuki, T., et al. (2005). Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Mol. Cancer Ther. 4, 257-270.
8. Diamandis, E.P., Scorilas, A., Fracchioli, S., Van Gramberen, M., De Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., et al. (2003). Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 21, 1035-1043.
9. Dong, S.M., Traverso, G., Johnson, C., Geng, L., Favis, R., Boynton, K., Hibi, K., Goodman, S.N., et al. (2001). Detecting colorectal cancer in stool with the use of multiple genetic targets. J. Natl. Cancer Inst. 93, 858-865.
10. Fang, J.Y. and Richardson, B.C. (2005). The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6, 322-327.
11. Fearon, E.R. and Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell 61, 759-767.
12. Ghosh, M.C., Grass, L., Soosaipillai, A., Sotiropoulou, G., and Diamandis, E.P. (2004). Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193-199.
13. Giehl, K. (2005). Oncogenic Ras in tumour progression and metastasis. Biol. Chem. 386, 193-205.
14. Hibi, K., Robinson, C.R., Booker, S., Wu, L., Hamilton, S.R., Sidransky, D., and Jen, J. (1998). Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res. 58, 1405-1407.
15. Ignatenko, N.A., Babbar, N., Mehta, D., Casero, R.A. Jr., and Gerner, E.W. (2004a). Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells. Mol. Carcinog. 39, 91-102.
16. Ignatenko, N.A., Zhang, H., Watts, G.S., Skovan, B.A., Stringer, D.E., and Gerner, E.W. (2004b). The chemopreventive agent α- difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells. Mol. Carcinog. 39, 221-233.
17. Klucky, B., Mueller, R., Vogt, I., Teurich, S., Hartenstein, B., Breuhahn, K., Flechtenmacher, C., Angel, P., et al. (2007). Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 67, 8198-8206.
18. Lenander, C., Habermann, J.K., Ost, A., Nilsson, B., Schimmelpenning, H., Tryggvason, K., and Auer, G. (2001). Laminin-5 γ2 chain expression correlates with unfavorable prognosis in colon carcinomas. Anal. Cell. Pathol. 22, 201-209.
19. Nagahara, H., Mimori, K., Utsunomiya, T., Barnard, G.F., Ohira, M., Hirakawa, K., and Mori, M. (2005). Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin. Cancer Res. 11, 6800-6806.
20. Obiezu, C.V. and Diamandis, E.P. (2005). Human tissue kallikrein gene family: applications in cancer. Cancer Lett. 224, 1-22.
21. Ogawa, K., Utsunomiya, T., Mimori, K., Tanaka, F., Inoue, H., Nagahara, H., Murayama, S., and Mori, M. (2005). Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin. Cancer Res. 11, 2889-2893.
22. Orian-Rousseau, V., Aberdam, D., Rousselle, P., Messent, A., Gavrilovic, J., Meneguzzi, G., Kedinger, M., and Simon-Assmann, P. (1998). Human colonic cancer cells synthesize and adhere to laminin-5. Their adhesion to laminin-5 involves multiple receptors among which is integrin α2β1. J. Cell Sci. 11, 1993-2004.
23. Pretlow, T.P. and Pretlow, T.G. (2005). Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim. Biophys. Acta 1756, 83-96.
24. Prezas, P., Arlt, M.J., Viktorov, P., Soosaipillai, A., Holzscheiter, L., Schmitt, M., Talieri, M., Diamandis, E.P., et al. (2006). Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol. Chem. 387, 807-811.
25. Pyke, C., Salo, S., Ralfkiaer, E., Romer, J., Dano, K., and Tryggvason, K. (1995). Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 55, 4132-4139.
26. Santin, A.D. Diamandis, E.P. Bellone, S., Soosaipillai, A., Cane, S., Palmieri, M., Burnett, A., Roman, J.J., et al. (2005). Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Clin. Cancer Res. 11, 3320-3325.
27. Schramm, K., Krause, K., Bittroff-Leben, A., Goldin-Lang, P., Thiel, E., and Kreuser, E.D. (2000). Activated K-ras is involved in regulation of integrin expression in human colon carcinoma cells. Int. J. Cancer 87, 155-164.
28. Shahrzad, S., Quayle, L., Stone, C., Plumb, C., Shirasawa, S., Rak, J.W., and Coomber, B.L. (2005). Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression. Cancer Res. 65, 8134-8141.
29. Turck, N., Gross, I., Gendry, P., Stutzmann, J., Freund, J.N., Kedinger, M., Simon-Assmann, P., and Launay, J.F. (2005). Laminin isoforms: biological roles and effects on the intracellular distribution of nuclear proteins in intestinal epithelial cells. Exp. Cell Res. 303, 494-503.
30. Wan, J., Zhang, Z.Q., You, W.D., Sun, H.K., Zhang, J.P., Wang, Y.H., and Fu, Y.H. (2004). Detection of K-ras gene mutation in fecal samples from elderly large intestinal cancer patients and its diagnostic significance. World J. Gastroenterol. 10, 743-746.
31. Wolf, W.C., Evans, D.M., Chao, L., and Chao, J. (2001). A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. Am. J. Pathol. 159, 1797-1805.
32. Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S. I., Rodriguez, A., Kogot, J.M., Scarisbrick, I.A., and Blaber, M., (2007). Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852-31864.